1.Introduction
The development of nanobioimaging agents possessing enhanced contrast, immunocompatibility, biocompatibility, increased circulation time in blood and proper clearance from body is a propelling research area of nanomedicine. Recently, various nanocontrast agents (e.g. gold, superparamagnetic iron oxide, gadolinium-based nanoparticle) including multimodal imaging agents (e.g. magentofluorescence, X-ray contrast agent with fluorescence meoity/MRI ability) are being explored for bioimaging applications to obtain precise information from the target site.
In order to apply these materials at the clinical phase, they should be investigated for following important biological studies: in vitro toxicity, 1 in vivo biodistribution/toxicity [2] [3] [4] and immunetoxicity. 5 Though most of the nanocontrast agents have been tested for in vitro cytotoxicity and to some extent, in vivo biodistribution, their immunogenicity studies are either rarely explored or they possess immnuotoxicity. We note that there are some reports available on the investigation of generation of reactive oxygen species (ROS) which is also an indicator of immune toxicity. 6 In summary, it is vital to explore the immune response of nanoparticles along with in vitro and in vivo toxicity studies.
Immune responses from the body are one of the complex biological mechanisms comprising of diverse signaling pathways. Once a foreign object (e.g. nanocontrast agents) enters the body, it is recognized as "non-self" by antigen presenting cells (APCs), such as macrophages and dendritic cells which trigger immune responses. Thus, it is essential to understand the immune response of newly developed nanocontrast agent, in addition to in vitro and in vivo tests. 
Generation of dendritic cells and macrophages
PBMCs were isolated from Buffy coats with Histopaque 1.077 by gradient centrifugation.
CD14+ve monocytes were purified with anti-CD14 magnetic beads (Miltenyi). Monocyte derived DCs were generated as previously described. 22, 23 Briefly, positively selected CD14+ monocytes were cultured in DC medium (RPMI, 10%FBS, 1% sodium pyruvate) containing rhGM-CSF and rhIL-4 (both 1000 U/mL). Additional complete medium with cytokines was added on day 3-4. 24 Macrophages were generated from CD14+ve cells by culture in ultra-low attachment plates for 5-6 days in complete medium (RPMI, 10% FBS, 1% sodium pyruvate) with 20 U/mL GM-CSF for generation of M1 or 10 ng/mL M-CSF for generation of M2 phenotype. Additional complete medium with cytokines was added on day 4. The phenotype of cells was confirmed by flow cytometry and profiling of cytokines released on maturation. DC and M1 MO were activated with LPS (500 ng/mL) and IFN-γ 1000 U/mL) for 24h, M2 macrophages were activated with LPS (500 ng/mL) alone.
Cell uptake and MTT assay studies.
For observing the internalization of polymer capsules, both mature DCs were seeded on sterile coverslips (50,000 cells per well) placed on 6-well plate. by washing twice with PBS prior to fixing with formaldehyde. Cell membranes were stained using deep red membrane dye (Cy5). MTT assay for quantifying cell viability was also carried out in same conditions as cell uptake studies. 25 UV-visible absorbance was recorded at 570 nm.
DC and MO phenotyping
Flow cytometry was performed on MACS Quant flow cytometer (Miltenyi and incubated for 2 h. A similar protocol was followed for M1 and M2 macrophages. The secretion of IL12p70 and IL10 was performed by commercial human ELISA kit (eBioscience and R&D Duoset respectively). The sensitivity of IL-12p70 ELISA was 7.8 pg/mL and IL-10 was 31.2 pg/mL. Absorbance was read at 450 nm wavelengths using a spectrometer.
Characterizations
The morphology of the samples was acquired from SUPRA ® Series Ultra High Resolution Field Emission-Scanning Electron Microscope FE-SEM (SEM). The formation of core-shell structure was visualized from Transmission Electron Microscope (TEM) images obtained using FEI Technai Twin microscope with high contrast and resolution at 20kV to 120kV. Internalization of polymer capsules in cells has been confirmed through images from laser scanning confocal microscope Carl Zeiss LSM 710 and LSM 810.UV-visible absorbance was recorded for MTT assay using Thermoscientific UV-Visible spectrophotometer.
Statistics
Statistical analysis was undertaken using Graphpad prism 5.0. ELISA assay data were plotted using mean ± SD and statistical significance determined with two-tailed t-test. In case of multiple data comparison, data is analyzed using one-way ANOVA test followed by Bonferroni post-test.
Results

Characteristics of nanoparticle-loaded capsules
Silica particles (~500 nm) were fabricated by modified Stöber's process. 26, 27 Lanthanide doped nanoparticles were coated over silica using a method adapted by Yu et al. 28 Synthesis of 
Interaction of capsules with DC and MO
Internalization of capsules was studied in DC, followed by quantification of interleukins to understand behavior of APCs on interaction with polymer capsules. In the case of cell uptake studies, CLSM images Figure Figure S1 represents MTT assay plot exhibiting biocompatibility of capsules with macrophages.
Capsules do not activate resting DC nor perturb DC activation
The purity and quality of generated DC was assessed by phenotypic analysis. In agreement with previous reports DC generated from CD14+ve monocytes in the presence of GM-CSF and IL-4
showed loss of CD14 expression, high HLA-DR and were positive for CD80, CD40, CD86 while CD83 expression was negative. 
Capsules do not alter the polarization of M1 or M2 macrophages
Macrophages are broadly classified into M1 and M2 type based on their phenotype and cytokine expression. M1 was confirmed by positive staining with CD68. Both M1 and M2 macrophages expressed HLA-DR, CD86 and CD80 which increased upon activation. Expression of HLA-DR and CD86 was greater in resting and activated M1 compared to M2 macrophages. CD83 and CD40 were absent on immature and mature M2 but whilst absent on immature M1 they were expressed by mature M1 (Figure S3a,b) . 30, 34 Mature M1 macrophages produced high levels on IL-12 and low IL-10 while mature M2 macrophages preferentially secreted IL-10 whereas IL-12 levels were low. M1 macrophages incubated with polymer capsules encapsulating nanoparticles expressed similar levels of IL-12
and IL-10 after LPS activation compared to control (only cells) indicating that they are not altering the immune response of cells (Figures 5a and c) . The polymer capsules were tested for its immunocompatibility by tracking the changes in interlukin secretions by APCs. Interleukins are also an indicator of reactive oxygen species (ROS) generation which leads to organ damage via inflammation. 6 Hanley et al. have reported
ZnO nanoparticles-induced enhanced secretion of proinflammatory cytokines in polymorphic blood mononuclear cells (PBMCs) and monocytes. 36 In another report, gadolinium nanoparticles were found to exhibit minimal immunotoxicity which was also quantified by interleukin secretions from blood serum. antigen-presentation and cross-presentation.
Conclusions
PEGylated polymer capsules encapsulating 
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